Friday, July 21, 2017 11:28:50 PM
“What the small companies need to do is show proof of concept. You have to hit your endpoints,” said Marban.
There is a desperate need for new therapies to treat heart failure, a chronic condition that prevents the heart from pumping blood as it should. The number of American adults with the disease could top 8 million by 2030, up from 5.7 million in 2012, while the cost of treatment could more than double, from $31 billion to $70 billion.
Each firm is taking a different approach to reach the same goal: bolstering the deteriorated muscle.''
http://news.heart.org/clinging-to-the-promise-of-heart-stem-cell-therapy/
emit...
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM